Pharmacokinetic/Pharmacodynamic (PK/PD) Modelling of Posaconazole against Candida glabrata: Determination of PK/PD Susceptibility Breakpoints for CLSI Method

Presenter
  • M. Beredaki
Session
Virtual 333 - AAR07 Antimicrobial Pharmacokinetics and Pharmacodynamics - Antimicrobial PK/PD

Previous ePoster
Effect of Probiotics on the Axillary Skin Microbiome of Healthy Adult Nigerians

Next ePoster
Evaluation of Extended Spectrum Beta Lactamase ( Esbl) and Risk Factors among Females with Community Acquired Urinary Tract Infections in Ogun State, Nigeria
Exploring the Potentials of Acinetobacter Baumanii Carbapenemase Bla-oxa Proteins in the Design of B and T Cell Multi-Epitope Subunit Vaccine Using Immunoinformatics Approach
Characterization of Stemphylium PNW2016-02, a Fungal Endophyte from Spinach
Overexpression of Aldo-keto Reductase and Short-chain Dehydrogenase Genes in Clostridium Beijerinckii Leads to Enhanced Butanol Production from Switchgrass Hydrolysates
In Vitro Activity of Ceftolozane/Tazobactam and Imipenem/Relebactam against Pseudomonas aeruginosa from Patients in the United States - SMART 2017-2018
Efhp, a Novel Calcium (Ca2+) Sensor of Pseudomonas Aeruginosa Mediates Ca2+ Regulation of Virulence
IBT-V02 Vaccine Protects against Staphylococcus aureus Skin and Soft Tissue Infection in Mouse and Rabbit Models
Bio-inspired Synthesis & Bio-catalytic Activity of Zinc Oxide Nanoparticles Using Seed Extract of Citrullus Lanatus against Antibiotics Resistant Pathogenic Bacteria
Novel In Vitro Porcine Urothelium Based Model for the Assessment of Avian Pathogenic Escherichia Coli
Visualization and Quantification of the Indigenous Gut Bacterial Growth by D-amino Acid-based Metabolic Labeling